ConductScience.org, home

Library / Trial comparisons

Baseline (Duke) vs Post Comfort Talk® Training: Oral Sedation Rate (Duke)

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

Measures 6

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

MeasureValue95% interval, lower95% interval, upperMethodNoteSource
Risk in group 10.02470.02030.0299wilsonClinicalTrials.gov
Risk in group 20.01440.01210.0171wilsonClinicalTrials.gov
Risk difference, group 1 minus group 20.01030.005150.016newcombe hybrid scoreClinicalTrials.gov
Risk ratio, group 1 over group 21.711.322.22logClinicalTrials.gov
Odds ratio, group 1 over group 21.731.332.25logClinicalTrials.gov
Number needed to treat, for one more participant with the outcome on Baseline (Duke) than on Post Comfort Talk® Training97.462.5194from the risk difference intervalClinicalTrials.gov

Groups 2

Neither group, or both, names a comparator, so the groups keep ClinicalTrials.gov's order.

GroupTitleDescriptionWith the outcomeAnalysedClinicalTrials.gov codeSource
Group 1Baseline (Duke)Patients who show for their MRI scans prior to team Training in Comfort Talk®1004,051OG000ClinicalTrials.gov
Group 2Post Comfort Talk® TrainingPatient who show for their MRI scans after team training in Comfort Talk®1288,879OG001ClinicalTrials.gov

Outcome 5

FieldValueSource
TypeSECONDARYClinicalTrials.gov
TitleOral Sedation Rate (Duke)ClinicalTrials.gov
DescriptionPatients who receive medical sedation on siteClinicalTrials.gov
Time frame9 months (3 months baseline, 6 months post training)ClinicalTrials.gov
PopulationPatients showing for their MRI scansClinicalTrials.gov

Trial 8

FieldValueSource
TitleComfort Talk and Economic Outcomes in MRIClinicalTrials.gov
NCT numberNCT02427737ClinicalTrials.gov
PhasesNAClinicalTrials.gov
ConditionsClaustrophobia, Complication of Diagnostic ProcedureClinicalTrials.gov
InterventionsComfort Talk® TrainingClinicalTrials.gov
Lead sponsorHypnalgesics, LLCClinicalTrials.gov
Results first posted2019-09-12ClinicalTrials.gov
Results on ClinicalTrials.govhttps://clinicaltrials.gov/study/NCT02427737?tab=resultsClinicalTrials.gov

Source 4

FieldValueSource
Releasetrial-comparisons-2026-03-23-0.1.0ClinicalTrials.gov
Release manifest SHA-256f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57ClinicalTrials.gov
AACT copy2026-03-23ClinicalTrials.gov
Tables readoutcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquetClinicalTrials.gov

The same record as JSON

Release trial-comparisons-2026-03-23-0.1.0

ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.

ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.